Pfizer Fined Record-Breaking $2.3 Billion for Marketing Fraud
Pharmaceutical giant Pfizer has been fined an unprecedented $2.3 billion for fraudulent marketing practices related to four of its drugs - Bextra, Geodon, Zyvox and Lyrica - which downplayed potential risks associated with them. This serves as a warning to other companies engaging in similar activities and raises questions about whether those behind exaggerated claims about COVID-19 dangers could face similar consequences.